School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore.
Colloids Surf B Biointerfaces. 2012 Apr 1;92:55-63. doi: 10.1016/j.colsurfb.2011.11.024. Epub 2011 Nov 20.
Nanoscale antibiotic delivery has emerged as a promising therapeutic means to treat lung biofilm infection owed to its sputum penetrating ability. Due to the high antibiotic dosage requirement in anti-biofilm therapy, the most suitable formulation for this purpose is the antibiotic nanoparticles themselves, instead of the more extensively studied antibiotic-loaded nano-carriers, which often exhibit low drug loading. The present work details the preparation and characterization of antibiotic nanoparticle complex (or nanoplex) by self-assembly amphiphile-polyelectrolyte complexation process. Ofloxacin (OFX) and levofloxacin (LEV) are used as the antibiotics with dextran sulfate (DXT) as the polyelectrolyte. The nanoplex possesses high drug loading (up to 80%) and size<400nm ideal for sputum penetration. Unlike existing methods to prepare drug nanoparticles, the present method is fast, energy-minimal, solvent-free, and highly efficient as manifested in nearly 100% of drug is transformed into nanoplex. The effects of drug-to-polyelectrolyte charge ratio, pH, drug, and salt concentrations on the nanoplex characteristics (i.e. size, stability, drug loading) are investigated from which the optimal preparation conditions have been identified. Higher complexation efficiency and stronger agglomeration tendency are observed for LEV nanoplex owed to its higher hydrophobicity. The antibiotics are completely released from the nanoplex in aqueous salt solution within 3h and their antimicrobial activity is preserved upon complexation. The nanoplex is readily transformed into amorphous dry powders that remain stable after one-month storage owed to the high glass transition temperature. The antibiotic nanoplexes are highly charged enabling their subsequent functionalization for targeted delivery and controlled drug release purposes.
纳米级抗生素递药系统已成为一种很有前途的治疗肺部生物膜感染的治疗方法,因为它具有穿透痰液的能力。由于在抗生物膜治疗中需要高剂量的抗生素,因此最适合的制剂是抗生素纳米颗粒本身,而不是更广泛研究的载抗生素纳米载体,因为后者往往药物载量较低。本工作详细介绍了通过自组装两亲性-聚电解质复合过程制备和表征抗生素纳米颗粒复合物(或纳米复合物)。左氧氟沙星(OFX)和左氧氟沙星(LEV)被用作抗生素,葡聚糖硫酸酯(DXT)被用作聚电解质。纳米复合物具有高载药量(高达 80%)和<400nm 的尺寸,非常适合穿透痰液。与现有的制备药物纳米颗粒的方法不同,本方法快速、能量最小、无溶剂、高效,几乎 100%的药物转化为纳米复合物。研究了药物与聚电解质电荷比、pH 值、药物和盐浓度对纳米复合物特性(即粒径、稳定性、载药量)的影响,确定了最佳的制备条件。由于其较高的疏水性,LEV 纳米复合物具有更高的复合物效率和更强的聚集趋势。抗生素在含盐水溶液中在 3 小时内完全释放,并且复合物化后保持其抗菌活性。纳米复合物很容易转化为无定形干燥粉末,在一个月的储存后仍保持稳定,这归因于其较高的玻璃化转变温度。抗生素纳米复合物带高电荷,使其能够进行后续的功能化,以实现靶向递送和控制药物释放的目的。